Finally, to address the putative link between CXCR3+ cancer cells and clinical prognosis, we clustered tumor samples from breast cancer patients according to the expression of CXCR3+ cell signature (CXCR3S) (Supplementary Table 3). This evidence concerns the gene CXCR3 and breast carcinoma.